Genmab A/S's market cap is currently kr117.60B. The company's EPS TTM is kr34.7841712876; its P/E ratio is 13.79; Genmab A/S is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is kr30.90. See an overview of income statement, balance sheet, and cash flow financials.
